BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 356960)

  • 1. The chemotherapy of Hodgkin's disease: past experiences and future directions.
    DeVita VT; Lewis BJ; Rozencweig M; Muggia FM
    Cancer; 1978 Aug; 42(2 Suppl):979-90. PubMed ID: 356960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
    Huguley CM; Durant JR; Moores RR; Chan YK; Dorfman RF; Johnson L
    Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation.
    Br Med J; 1975 Aug; 3(5980):413-4. PubMed ID: 1098721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy and survival in advanced Hodgkin's disease.
    Canellos GP; Young RC; Berard CW; DeVita VT
    Arch Intern Med; 1973 Mar; 131(3):388-90. PubMed ID: 4569375
    [No Abstract]   [Full Text] [Related]  

  • 5. Prednisone in MOPP chemotherapy for Hodgkin's disease.
    Jacobs C; Portlock CS; Rosenberg SA
    Br Med J; 1976 Dec; 2(6050):1469-71. PubMed ID: 1000259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
    Moore MR; Jones SE; Bull JM; William LA; Rosenberg SA
    Cancer; 1973 Jul; 32(1):52-60. PubMed ID: 4716784
    [No Abstract]   [Full Text] [Related]  

  • 7. Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.
    Bloomfield CD; Weiss RB; Fortuny I; Vosika G; Kennedy BJ
    Cancer; 1976 Jul; 38(1):42-8. PubMed ID: 947533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E; Kende G; Many A; Ramot B
    Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined radiotherapy and chemotherapy in the treatment of Hodgkin's disease.
    Tubiana M; Mathé G
    Ser Haematol; 1973; 6(2):202-43. PubMed ID: 4206180
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
    J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy.
    Rosenberg SA; Kaplan HS
    Cancer; 1975 Jan; 35(1):55-63. PubMed ID: 803252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy of Hodgkin's disease in children.
    Kolygin BA
    Cancer; 1976 Oct; 38(4):1494-7. PubMed ID: 991072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission.
    Frei E; Luce JK; Gamble JF; Coltman CA; Constanzi JJ; Talley RW; Monto RW; Wilson HE; Hewlett JS; Delaney FC; Gehan EA
    Ann Intern Med; 1973 Sep; 79(3):376-82. PubMed ID: 4748254
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.
    Bonadonna G; Zucali R; De Lena M; Valagussa P
    Cancer Treat Rep; 1977 Aug; 61(5):769-77. PubMed ID: 70270
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy of advanced Hodgkin's disease. A review.
    Goldsmith MA; Carter SK
    Cancer; 1974 Jan; 33(1):1-8. PubMed ID: 4129559
    [No Abstract]   [Full Text] [Related]  

  • 16. [81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)].
    Baillet F; Brun B; Maylin C; Mazeron JJ; Pierquin B; Dreyfus B
    J Radiol Electrol Med Nucl; 1977 May; 58(5):343-6. PubMed ID: 886528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood Hodgkin's disease in Uganda: a ten year experience.
    Olweny CL; Katongole-Mbidde E; Kiire C; Lwanga SK; Magrath I; Ziegler JL
    Cancer; 1978 Aug; 42(2):787-92. PubMed ID: 687386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined chemotherapy in Hodgkin's disease].
    Somers R; Haanen C; Hart AA; Kroese WF; Sizoo W; Wagener DJ
    Ned Tijdschr Geneeskd; 1976 Jun; 120(24):1038-43. PubMed ID: 1272447
    [No Abstract]   [Full Text] [Related]  

  • 19. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
    Osieka R; Bruntsch U; Gallmeier WM; Seeber S; Schmidt CG
    Dtsch Med Wochenschr; 1976 Aug; 101(32):1177-82. PubMed ID: 59661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MOPP chemotherapy of generalized Hodgkin's disease].
    Zieliński T; Krajewska B; Solska E; Karnicka-Młodkowska H
    Nowotwory; 1978 Dec; 28(4):453-9. PubMed ID: 733603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.